Vertex Pharmaceuticals price target raised to $665 by Morgan Stanley
Morgan Stanley announced a $665.00 per-share price target for Vertex Pharmaceuticals.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.